MYC and breast cancer: For instance, CK2 phosphorylates p53 at Ser 392 in response to DNA damage [29]; regulates c-myc protein stability in lymphomagenesis [30]; promotes aberrant activation of nuclear factor-kappa B (NF-κB) in breast cancer cells [31].